Sudden severe hyperammonemia and status epilepticus -a case report-

Korean Journal of Anesthesiology

Volumn 65, Issue 3, 2013, Pages 262-265

  Shin, Woo Kyung ^a   Jang, Young Eun ^a   Lee, Hannah ^a   Min, Se Hee ^a   Ryu, Ho Geol ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Hyperammonemia; Seizures; Status epilepticus

Indexed keywords

BENZOIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; LORAZEPAM; MANNITOL; MIDAZOLAM; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL TENDERNESS; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; COLON PERFORATION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS RENAL REPLACEMENT THERAPY; CYANOSIS; DEATH; DYSPNEA; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; FEVER; FOCAL EPILEPSY; FOLLOW UP; HUMAN; HYPERAMMONEMIA; HYPOTENSION; LOADING DRUG DOSE; METABOLIC ALKALOSIS; NEUTROPENIA; NEUTROPHIL COUNT; RESPIRATORY ALKALOSIS; SEIZURE; SEPSIS; SEPTIC SHOCK; TACHYPNEA; TONIC CLONIC SEIZURE; TOTAL COLON RESECTION;

EID: 84885049010     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2013.65.3.262     Document Type: Article

References (15)

1. American Psychiatric Association. Diagnostic and statistical manual. 4th ed. Washington DC, APA Press. 1994.
2. Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol 2004; 11: 800-10.
3. Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 2003; 23: 259-69.
4. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci 2005; 62: 2295-304.
5. Frontera JA. Delirium and sedation in the ICU. Neurocrit Care 2011; 14: 463-74.
6. Batshaw ML. Hyperammonemia. Curr Probl Pediatr 1984; 14: 6-69.
7. Walker V. Severe hyperammonaemia in adults not explained by liver disease. Ann Clin Biochem 2012; 49: 214-28.
8. Nott L, Price TJ, Pittman K, Patterson K, Fletcher J. Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy. Leuk Lymphoma 2007; 48: 1702-11.
9. Advani PP, Fakih MG. 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine. Anticancer Res 2011; 31: 335-8.
10. Moffatt-Bruce SD, Pesavento T, Von Viger J, Nunley D, Pope-Harman A, Martin S, et al. Successful management of immunosuppression in a patient with severe hyperammonemia after lung transplantation. J Heart Lung Transplant 2008; 27: 801-3.
11. Tse N, Cederbaum S, Glaspy JA. Hyperammonemia following allogeneic bone marrow transplantation. Am J Hematol 1991; 38: 140-1.
12. Hu WT, Kantarci OH, Merritt JL 2nd, McGrann P, Dyck PJ, Lucchinetti CF, et al. Ornithine transcarbamylase deficiency presenting as encephalopathy during adulthood following bariatric surgery. Arch Neurol 2007; 64: 126-8.
13. Singh RH. Nutritional management of patients with urea cycle disorders. J Inherit Metab Dis 2007; 30: 880-7.
14. Leonard JV, McKiernan PJ. The role of liver transplantation in urea cycle disorders. Mol Genet Metab 2004; 81 Suppl 1: S74-8.
15. Clay AS, Hainline BE. Hyperammonemia in the ICU. Chest 2007; 132: 1368-78.